2 matches for your search in the start-up spotlight
rssLaxxon Medical was founded in 2017. We hold the exclusive worldwide rights to the patented use and application of 3D screen printing technology for the development, manufacture and commercialization of pharmaceutical dosage forms. With our innovative SPID®-Technology (Screen Printing ...
Gotham Therapeutics has assembled an exceptional team and network to establish a novel drug class targeting RNA-modifying proteins. By changing the activity of proteins that modify messenger RNA, we aim to develop new treatment options for patients suffering from cancers, auto-immune and ...